Investors can benefit from certain health care companies that will be boosted by the stimulus package, said Les Funtleyder, health care strategist of Miller Tabak.
“We’re just looking at fundamentals rather than macro,” he told CNBC. “We’re looking specifically at the genetic analysis space like the Illuminas and Luminexes of the world.”
“We also like the vaccine and diagnostic companies,” said Funtleyder.
However, he said investors who are worried about risk should avoid the long-term care facilities.
Funtleyer does not own shares of any of the companies mentioned above.